Form 4: Immuneering CPO Acquires Shares via ESPP

Immuneering Corp's Chief People Officer, Leah R. Neufeld, acquired 11,815 shares of Class A Common Stock through the company's Employee Stock Purchase Plan.

Summary

• Leah R. Neufeld, Chief People Officer of Immuneering Corp, acquired shares of the company's Class A Common Stock.
• The acquisition involved 11,815 shares at a price of $1.428 per share.
• The transaction occurred on September 15, 2025, as part of the Immuneering Corporation 2021 Employee Stock Purchase Plan (ESPP).
• Following this transaction, Ms. Neufeld beneficially owns a total of 22,544 shares of Class A Common Stock.
• The shares were purchased at a price not less than 85% of the Fair Market Value on the Enrollment Date of the relevant Offering Period, in accordance with the ESPP.

Sentiment

Score: 7

Explanation: The Chief People Officer's acquisition of shares through a routine employee stock purchase plan suggests a degree of insider confidence in the company's prospects.

Positives

• The Chief People Officer's participation in the Employee Stock Purchase Plan and acquisition of shares indicates a degree of insider confidence in the company's future.

Stakeholder Impact

• Shareholders may view the insider purchase as a minor positive signal of management's confidence in the company's future.

Key Dates

Recommendation

While the insider purchase through an ESPP is a minor positive indicator of management's belief in the company, it is a routine transaction and not significant enough to alter an investment thesis or warrant a strong buy or sell recommendation based solely on this filing.

Keywords

Immuneering Corp, IMRX, insider transaction, Form 4, stock purchase, ESPP, employee stock plan, Leah R. Neufeld